Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244374 | SCV000315969 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000244374 | SCV000338322 | benign | not specified | 2015-12-09 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000244374 | SCV000538604 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Labcorp Genetics |
RCV001516684 | SCV001724997 | benign | Primary ciliary dyskinesia | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001707599 | SCV001936461 | benign | not provided | 2018-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001516684 | SCV002755608 | benign | Primary ciliary dyskinesia | 2016-07-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001707599 | SCV005313322 | benign | not provided | criteria provided, single submitter | not provided |